Healing the Broken Heart; The Immunomodulatory Effects of Stem Cell Therapy

Cardiovascular Disease (CVD) is a leading cause of mortality within the United States. Current treatments being administered to patients who suffered a myocardial infarction (MI) have increased patient survival, but do not facilitate the replacement of damaged myocardium. Recent studies demonstrate...

Full description

Bibliographic Details
Main Authors: Marcus J. Wagner, Mohsin Khan, Sadia Mohsin
Format: Article
Language:English
Published: Frontiers Media S.A. 2020-04-01
Series:Frontiers in Immunology
Subjects:
Online Access:https://www.frontiersin.org/article/10.3389/fimmu.2020.00639/full
_version_ 1818843005434462208
author Marcus J. Wagner
Mohsin Khan
Mohsin Khan
Sadia Mohsin
Sadia Mohsin
author_facet Marcus J. Wagner
Mohsin Khan
Mohsin Khan
Sadia Mohsin
Sadia Mohsin
author_sort Marcus J. Wagner
collection DOAJ
description Cardiovascular Disease (CVD) is a leading cause of mortality within the United States. Current treatments being administered to patients who suffered a myocardial infarction (MI) have increased patient survival, but do not facilitate the replacement of damaged myocardium. Recent studies demonstrate that stem cell-based therapies promote myocardial repair; however, the poor engraftment of the transferred stem cell populations within the infarcted myocardium is a major limitation, regardless of the cell type. One explanation for poor cell retention is attributed to the harsh inflammatory response mounted following MI. The inflammatory response coupled to cardiac repair processes is divided into two distinct phases. The first phase is initiated during ischemic injury when necrosed myocardium releases Danger Associated Molecular Patterns (DAMPs) and chemokines/cytokines to induce the activation and recruitment of neutrophils and pro-inflammatory M1 macrophages (MΦs); in turn, facilitating necrotic tissue clearance. During the second phase, a shift from the M1 inflammatory functional phenotype to the M2 anti-inflammatory and pro-reparative functional phenotype, permits the resolution of inflammation and the establishment of tissue repair. T-regulatory cells (Tregs) are also influential in mediating the establishment of the pro-reparative phase by directly regulating M1 to M2 MΦ differentiation. Current studies suggest CD4+ T-lymphocyte populations become activated when presented with autoantigens released from the injured myocardium. The identity of the cardiac autoantigens or paracrine signaling molecules released from the ischemic tissue that directly mediate the phenotypic plasticity of T-lymphocyte populations in the post-MI heart are just beginning to be elucidated. Stem cells are enriched centers that contain a diverse paracrine secretome that can directly regulate responses within neighboring cell populations. Previous studies identify that stem cell mediated paracrine signaling can influence the phenotype and function of immune cell populations in vitro, but how stem cells directly mediate the inflammatory microenvironment of the ischemic heart is poorly characterized and is a topic of extensive investigation. In this review, we summarize the complex literature that details the inflammatory microenvironment of the ischemic heart and provide novel insights regarding how paracrine mediated signaling produced by stem cell-based therapies can regulate immune cell subsets to facilitate pro-reparative myocardial wound healing.
first_indexed 2024-12-19T04:50:59Z
format Article
id doaj.art-e246a31a3ffb4e789d8b43ca15d14463
institution Directory Open Access Journal
issn 1664-3224
language English
last_indexed 2024-12-19T04:50:59Z
publishDate 2020-04-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Immunology
spelling doaj.art-e246a31a3ffb4e789d8b43ca15d144632022-12-21T20:35:22ZengFrontiers Media S.A.Frontiers in Immunology1664-32242020-04-011110.3389/fimmu.2020.00639521130Healing the Broken Heart; The Immunomodulatory Effects of Stem Cell TherapyMarcus J. Wagner0Mohsin Khan1Mohsin Khan2Sadia Mohsin3Sadia Mohsin4Independence Blue Cross Cardiovascular Research Center, Lewis Katz School of Medicine at Temple University, Philadelphia, PA, United StatesCenter for Metabolic Disease, Lewis Katz School of Medicine at Temple University, Philadelphia, PA, United StatesDepartment of Physiology, Lewis Katz School of Medicine at Temple University, Philadelphia, PA, United StatesIndependence Blue Cross Cardiovascular Research Center, Lewis Katz School of Medicine at Temple University, Philadelphia, PA, United StatesDepartment of Pharmacology, Lewis Katz School of Medicine at Temple University, Philadelphia, PA, United StatesCardiovascular Disease (CVD) is a leading cause of mortality within the United States. Current treatments being administered to patients who suffered a myocardial infarction (MI) have increased patient survival, but do not facilitate the replacement of damaged myocardium. Recent studies demonstrate that stem cell-based therapies promote myocardial repair; however, the poor engraftment of the transferred stem cell populations within the infarcted myocardium is a major limitation, regardless of the cell type. One explanation for poor cell retention is attributed to the harsh inflammatory response mounted following MI. The inflammatory response coupled to cardiac repair processes is divided into two distinct phases. The first phase is initiated during ischemic injury when necrosed myocardium releases Danger Associated Molecular Patterns (DAMPs) and chemokines/cytokines to induce the activation and recruitment of neutrophils and pro-inflammatory M1 macrophages (MΦs); in turn, facilitating necrotic tissue clearance. During the second phase, a shift from the M1 inflammatory functional phenotype to the M2 anti-inflammatory and pro-reparative functional phenotype, permits the resolution of inflammation and the establishment of tissue repair. T-regulatory cells (Tregs) are also influential in mediating the establishment of the pro-reparative phase by directly regulating M1 to M2 MΦ differentiation. Current studies suggest CD4+ T-lymphocyte populations become activated when presented with autoantigens released from the injured myocardium. The identity of the cardiac autoantigens or paracrine signaling molecules released from the ischemic tissue that directly mediate the phenotypic plasticity of T-lymphocyte populations in the post-MI heart are just beginning to be elucidated. Stem cells are enriched centers that contain a diverse paracrine secretome that can directly regulate responses within neighboring cell populations. Previous studies identify that stem cell mediated paracrine signaling can influence the phenotype and function of immune cell populations in vitro, but how stem cells directly mediate the inflammatory microenvironment of the ischemic heart is poorly characterized and is a topic of extensive investigation. In this review, we summarize the complex literature that details the inflammatory microenvironment of the ischemic heart and provide novel insights regarding how paracrine mediated signaling produced by stem cell-based therapies can regulate immune cell subsets to facilitate pro-reparative myocardial wound healing.https://www.frontiersin.org/article/10.3389/fimmu.2020.00639/fullmyocardial infarctionstem cell therapywound healingimmune responseimmunomodulation
spellingShingle Marcus J. Wagner
Mohsin Khan
Mohsin Khan
Sadia Mohsin
Sadia Mohsin
Healing the Broken Heart; The Immunomodulatory Effects of Stem Cell Therapy
Frontiers in Immunology
myocardial infarction
stem cell therapy
wound healing
immune response
immunomodulation
title Healing the Broken Heart; The Immunomodulatory Effects of Stem Cell Therapy
title_full Healing the Broken Heart; The Immunomodulatory Effects of Stem Cell Therapy
title_fullStr Healing the Broken Heart; The Immunomodulatory Effects of Stem Cell Therapy
title_full_unstemmed Healing the Broken Heart; The Immunomodulatory Effects of Stem Cell Therapy
title_short Healing the Broken Heart; The Immunomodulatory Effects of Stem Cell Therapy
title_sort healing the broken heart the immunomodulatory effects of stem cell therapy
topic myocardial infarction
stem cell therapy
wound healing
immune response
immunomodulation
url https://www.frontiersin.org/article/10.3389/fimmu.2020.00639/full
work_keys_str_mv AT marcusjwagner healingthebrokenhearttheimmunomodulatoryeffectsofstemcelltherapy
AT mohsinkhan healingthebrokenhearttheimmunomodulatoryeffectsofstemcelltherapy
AT mohsinkhan healingthebrokenhearttheimmunomodulatoryeffectsofstemcelltherapy
AT sadiamohsin healingthebrokenhearttheimmunomodulatoryeffectsofstemcelltherapy
AT sadiamohsin healingthebrokenhearttheimmunomodulatoryeffectsofstemcelltherapy